We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.77B
AUM Growth
+$297M
Cap. Flow
+$195M
Cap. Flow %
11%
Top 10 Hldgs %
25.89%
Holding
186
New
46
Increased
63
Reduced
28
Closed
46

Top Buys

Rank Stock Value
1
CPAY icon
Corpay
CPAY
+$50.4M
2
BMY icon
Bristol-Myers Squibb
BMY
+$40.6M
3
CNC icon
Centene
CNC
+$33.7M
4
CLVT icon
Clarivate
CLVT
+$27.5M
5
BAX icon
Baxter International
BAX
+$23.8M

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$35.3M
2
CRM icon
Salesforce
CRM
+$28.3M
3
FLEX icon
Flex
FLEX
+$21.2M
4
IPGP icon
IPG Photonics
IPGP
+$18.1M
5
LYFT icon
Lyft
LYFT
+$17.6M

Sector Composition

Rank Sector Weight
1 Technology 30.43%
2 Healthcare 14.56%
3 Communication Services 14.3%
4 Consumer Discretionary 11.94%
5 Industrials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FISV
26
Fiserv Inc
FISV
$27.4B
$23M 1.3%
203,160
+121,118
+148% +$13.3M
EXPE icon
27
Expedia Group
EXPE
$37.2B
$22.9M 1.3%
236,406
+116,543
+97% +$12.2M
BAX icon
28
Baxter International
BAX
$14.3B
$22.8M 1.29%
+562,140
New +$23.8M
NVEI
29
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$22.3M 1.26%
512,512
+44,242
+9% +$1.54M
GPN icon
30
Global Payments
GPN
$22.6B
$21.2M 1.2%
+201,870
New +$21.9M
CTSH icon
31
Cognizant
CTSH
$26B
$20.6M 1.16%
337,868
+9,237
+3% +$578K
BPOP icon
32
Popular Inc
BPOP
$11.2B
$19.5M 1.1%
339,811
+182,901
+117% +$11.9M
LAUR icon
33
Laureate Education
LAUR
$5.22B
$19.1M 1.08%
1,627,621
+712,653
+78% +$7.84M
RAMP icon
34
LiveRamp
RAMP
$2.3B
$19M 1.07%
866,762
-275,063
-24% -$6.56M
BTG icon
35
B2Gold
BTG
$6.71B
$18.9M 1.07%
4,777,433
+1,654,813
+53% +$6.16M
VRN
36
DELISTED
Veren
VRN
$17.5M 0.99%
2,485,303
+62,933
+3% +$436K
LYFT icon
37
Lyft
LYFT
$6.49B
$16M 0.9%
1,725,863
-1,454,816
-46% -$17.6M
FFIV icon
38
F5
FFIV
$23.5B
$15.6M 0.88%
106,825
+58,093
+119% +$8.39M
MDT icon
39
Medtronic
MDT
$113B
$15.3M 0.87%
190,306
+55,789
+41% +$4.55M
EMN icon
40
Eastman Chemical
EMN
$8.34B
$14.5M 0.82%
172,256
+78,750
+84% +$6.76M
HBI
41
DELISTED
Hanesbrands
HBI
$14.5M 0.82%
2,750,911
-950,057
-26% -$5.98M
AKAM icon
42
Akamai
AKAM
$16.9B
$14.4M 0.81%
+183,331
New +$14.8M
BLCO icon
43
Bausch + Lomb
BLCO
$6.01B
$13.9M 0.79%
800,926
-75,448
-9% -$1.28M
SWN
44
DELISTED
Southwestern Energy Company
SWN
$13.1M 0.74%
+2,621,741
New +$13.9M
ELAN icon
45
Elanco Animal Health
ELAN
$11B
$13.1M 0.74%
1,391,933
+1,073,104
+337% +$12.7M
KRC icon
46
Kilroy Realty
KRC
$4.32B
$12.7M 0.72%
393,117
+263,368
+203% +$9.6M
SNAP icon
47
Snap
SNAP
$9.05B
$12.1M 0.68%
1,079,147
+27,550
+3% +$289K
EXFY icon
48
Expensify
EXFY
$229M
$12M 0.68%
1,472,401
+36,043
+3% +$321K
FUN icon
49
Cedar Fair
FUN
$1.7B
$11.6M 0.66%
254,415
+58,444
+30% +$2.57M
HSII
50
DELISTED
Heidrick & Struggles
HSII
$11.5M 0.65%
377,860
-70,674
-16% -$2.16M
1
2
3 4 5

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return

Invenomic Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Invenomic Capital Management held 186 positions worth $1.77B, up 20% from $1.47B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Invenomic Capital Management deployed $195M of net new capital in Q1 2023, opening 46 new positions and adding to 63 existing holdings. Its largest new stake was Corpay: 248,424 shares worth $52.4M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Applovin, an estimated $35.3M trimmed.

  • Invenomic Capital Management's largest Q1 2023 buy was Corpay: 248,424 shares worth $52.4M.
  • Invenomic Capital Management added most to Centene in Q1 2023, an estimated $33.7M increase.
  • Invenomic Capital Management's biggest Q1 2023 reduction was Applovin, cutting an estimated $35.3M.
  • Invenomic Capital Management fully exited Salesforce in Q1 2023, selling an estimated $28.3M.
  • Invenomic Capital Management's ten largest holdings make up 26% of its $1.77B portfolio in Q1 2023.
  • Invenomic Capital Management opened 46 new positions and closed 46 in Q1 2023.
  • Invenomic Capital Management's portfolio value rose 20% quarter-over-quarter to $1.77B.

Based on Invenomic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.